Lewy body dementia is a condition that closely resembles two other conditions, Alzheimer’s disease and Parkinson’s disease. Because of its similarity to these other more common diseases and unfamiliarity with the condition, Lewy body dementia oftentimes goes undiagnosed. Lewy body dementia is also difficult to diagnose because the symptoms present themselves differently in each person. In order to receive a clear diagnosis, individuals should be seen by medical professionals that specialize in the diagnosis and treatment of dementias.

To learn more about Lewy body dementia, please follow the attached link to the Lewy Body Dementia Association’s website: http://www.lbda.org/

The following video explains the importance of participating in an LBD clinical trial:


Lewy Body Dementia Association Research Center of Excellence

Lewy Body RCOE logoUNC Neurology has been named a LBDA Research Center of Excellence (RCOE) by the Lewy Body Dementia Association (LBDA), the leading advocacy group dedicated to raising awareness and advancing research about Lewy body dementia (LBD). This collaboration features 25 preeminent academic medical research centers across the United States, coordinated by Mayo Clinic.

The LBDA RCOE program provides a centralized, coordinated research resource, supporting an expanded effort in conducting clinical trials related to LBD while helping to provide expert clinical care for patients, families and caregivers.